Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Modulation Therapeutics Inc.
DescriptionCD44 inhibitor
Molecular Target CD44
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple myeloma (MM)
Indication DetailsTreat multiple myeloma (MM)
Regulatory Designation
PartnerH. Lee Moffitt Cancer Center and Research Institute

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today